Correlation between sleep and quality of life in people with Parkinson’s disease treated with continuous subcutaneous infusion of foslevodopa/foscarbidopa
Irene A. Malaty(University of Florida), К. Ray Chaudhuri(NIHR Maudsley Dementia Biomedical Research Unit), Lars Bergmann(Universitätsklinikum Knappschaftskrankenhaus Bochum), Bruno Bergmans(AZ Sint-Jan), Eleni Okeanis Vaou(The University of Texas at San Antonio Health Science Center), Robert A. Hauser(University of South Florida), Luke Harmer(AbbVie (United States)), Per Odin(Lund University), Resmi Gupta(AbbVie (United States)), Megha Shah(Emory University)
Cited by 1
Related Papers
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
|Movement Disorders|2006|1.1k
Prevalence of and Factors Associated With Nurse Burnout in the US
|JAMA Network Open|2021|661
High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor
|Annals of Neurology|1997|484
Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association Studies
|American Journal of Psychiatry|2019|449